S were found to have similar or higher efficacy based on the effective drug concentration resulting in 10-fold reduction of RT activity (EC90). On average, 5-fold higher therapeutic levels of nanodrugs compared to EC90 levels observed in the infected MDM could be reached in the brain even 24h after the systemic administration of BP2-NG/NTP. The reported here nano-NRTI approach is the further step